CUTANEOUS SQUAMOUS CELL A091802

Study #A091802

Phase II randomized trial of avelumab plus cetuximab versus avelumab alone in advanced cutaneous squamous cell carcinoma of the skin (cSCC)

Back To Clinical Trials